Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1838

1.

Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.

Sclafani F, Hulkki Wilson S, Cunningham D, Gonzalez De Castro D, Kalaitzaki E, Begum R, Wotherspoon A, Capdevila J, Glimelius B, Roselló S, Thomas J, Tait D, Brown G, Oates J, Chau I.

Int J Cancer. 2019 Jun 14. doi: 10.1002/ijc.32507. [Epub ahead of print]

PMID:
31199501
2.

Correction: Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 May 30. doi: 10.1038/s41388-019-0835-1. [Epub ahead of print]

PMID:
31147600
3.

CPD preferences and activities of general practitioners, registered pharmacy staff and general practice nurses in NHS Scotland - a questionnaire survey.

Cunningham DE, Alexander A, Luty S, Zlotos L.

Educ Prim Care. 2019 May 30:1-10. doi: 10.1080/14739879.2019.1617644. [Epub ahead of print]

PMID:
31145862
4.

Detecting and Tracking Circulating Tumour DNA Copy Number Profiles during First Line Chemotherapy in Oesophagogastric Adenocarcinoma.

Davidson M, Barber LJ, Woolston A, Cafferkey C, Mansukhani S, Griffiths B, Moorcraft SY, Rana I, Begum R, Assiotis I, Matthews N, Rao S, Watkins D, Chau I, Cunningham D, Starling N, Gerlinger M.

Cancers (Basel). 2019 May 27;11(5). pii: E736. doi: 10.3390/cancers11050736.

5.

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes.

Ragulan C, Eason K, Fontana E, Nyamundanda G, Tarazona N, Patil Y, Poudel P, Lawlor RT, Del Rio M, Koo SL, Tan WS, Sclafani F, Begum R, Teixeira Mendes LS, Martineau P, Scarpa A, Cervantes A, Tan IB, Cunningham D, Sadanandam A.

Sci Rep. 2019 May 21;9(1):7665. doi: 10.1038/s41598-019-43492-0.

6.

Exploratory Analysis of Plasma Neurotensin as a Novel Biomarker for Early Detection of Colorectal Polyp and Cancer.

Qiu S, Nikolaou S, Fiorentino F, Rasheed S, Darzi A, Cunningham D, Tekkis P, Kontovounisios C.

Horm Cancer. 2019 Jun;10(2-3):128-135. doi: 10.1007/s12672-019-00364-3. Epub 2019 May 15.

PMID:
31093954
7.

International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis.

Scott AJ, Alexander JL, Merrifield CA, Cunningham D, Jobin C, Brown R, Alverdy J, O'Keefe SJ, Gaskins HR, Teare J, Yu J, Hughes DJ, Verstraelen H, Burton J, O'Toole PW, Rosenberg DW, Marchesi JR, Kinross JM.

Gut. 2019 May 15. pii: gutjnl-2019-318556. doi: 10.1136/gutjnl-2019-318556. [Epub ahead of print]

8.

Comparison of Tibiotalocalcaneal Arthrodeses Using a Sustained Dynamic Compression Nail Versus Nondynamized Nails.

Steele JR, Kildow BJ, Cunningham DJ, Dekker TJ, DeOrio JK, Easley ME, Nunley JA, Parekh SG, Adams SB.

Foot Ankle Spec. 2019 Apr 25:1938640019843332. doi: 10.1177/1938640019843332. [Epub ahead of print]

PMID:
31018671
9.

CEA expression heterogeneity and plasticity confer resistance to the CEA-targeting bispecific immunotherapy antibody cibisatamab (CEA-TCB) in patient-derived colorectal cancer organoids.

Gonzalez-Exposito R, Semiannikova M, Griffiths B, Khan K, Barber LJ, Woolston A, Spain G, von Loga K, Challoner B, Patel R, Ranes M, Swain A, Thomas J, Bryant A, Saffery C, Fotiadis N, Guettler S, Mansfield D, Melcher A, Powles T, Rao S, Watkins D, Chau I, Matthews N, Wallberg F, Starling N, Cunningham D, Gerlinger M.

J Immunother Cancer. 2019 Apr 15;7(1):101. doi: 10.1186/s40425-019-0575-3.

10.

Online recruitment of a non-help-seeking sample for an internet intervention: Lessons learned in an alcohol-exposed pregnancy risk reduction study.

MacDonnell K, Cowen E, Cunningham DJ, Ritterband L, Ingersoll K.

Internet Interv. 2019 Mar 11;17:100240. doi: 10.1016/j.invent.2019.100240. eCollection 2019 Sep.

11.

miR-31-3p Expression and Benefit from Anti-EGFR Inhibitors in Metastatic Colorectal Cancer Patients Enrolled in the Prospective Phase II PROSPECT-C Trial.

Anandappa G, Lampis A, Cunningham D, Khan KH, Kouvelakis K, Vlachogiannis G, Hedayat S, Tunariu N, Rao S, Watkins D, Starling N, Braconi C, Darvish-Damavandi M, Lote H, Thomas J, Peckitt C, Kalaitzaki R, Khan N, Fotiadis N, Rugge M, Begum R, Rana I, Bryant A, Hahne JC, Chau I, Fassan M, Valeri N.

Clin Cancer Res. 2019 Apr 5. doi: 10.1158/1078-0432.CCR-18-3769. [Epub ahead of print]

PMID:
30952636
12.

Clinical Impact of Routine Complete Blood Counts Following Total Knee Arthroplasty.

Howell EP, Kildow BJ, Karas V, Green CL, Cunningham DJ, Ryan SP, Bolognesi MP, Seyler TM.

J Arthroplasty. 2019 Jul;34(7S):S168-S172. doi: 10.1016/j.arth.2019.03.016. Epub 2019 Mar 12.

PMID:
30948289
13.

A Golden Conundrum.

Garner JL, Donovan J, Meireles I, Padley SPG, Cunningham D, Shah PL.

Am J Respir Crit Care Med. 2019 Apr 2. doi: 10.1164/rccm.201811-2222IM. [Epub ahead of print] No abstract available.

PMID:
30939047
14.

100 notable names from general practice.

Cunningham D.

Educ Prim Care. 2019 Apr 1:1. doi: 10.1080/14739879.2019.1595166. [Epub ahead of print] No abstract available.

PMID:
30929612
15.

Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study.

Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, Anthony A, Corrie P, Falk S, Finch-Jones M, Wasan H, Ross P, Wall L, Wadsley J, Evans JTR, Stocken D, Praseedom R, Ma YT, Davidson B, Neoptolemos JP, Iveson T, Raftery J, Zhu S, Cunningham D, Garden OJ, Stubbs C, Valle JW, Bridgewater J; BILCAP study group.

Lancet Oncol. 2019 May;20(5):663-673. doi: 10.1016/S1470-2045(18)30915-X. Epub 2019 Mar 25. Erratum in: Lancet Oncol. 2019 Apr 2;:.

PMID:
30922733
16.

Best Buy in Public Health or Luxury Expense?: The Cost-effectiveness of a Pediatric Operating Room in Uganda From the Societal Perspective.

Yap A, Cheung M, Muzira A, Healy J, Kakembo N, Kisa P, Cunningham D, Youngson G, Sekabira J, Yaesoubi R, Ozgediz D.

Ann Surg. 2019 Mar 19. doi: 10.1097/SLA.0000000000003263. [Epub ahead of print]

PMID:
30907755
17.

Primary Tumor Resection in Patients with Incurable Localized or Metastatic Colorectal Cancer: A Systematic Review and Meta-analysis.

Simillis C, Kalakouti E, Afxentiou T, Kontovounisios C, Smith JJ, Cunningham D, Adamina M, Tekkis PP.

World J Surg. 2019 Jul;43(7):1829-1840. doi: 10.1007/s00268-019-04984-2. Review.

18.

Recently-qualified general practitioners' perceptions and experiences of General Practice Specialty Training (GPST) in deprived areas of NHS Scotland - a qualitative study.

Cunningham D, Yeoman L.

Educ Prim Care. 2019 Mar 19:1-7. doi: 10.1080/14739879.2019.1587317. [Epub ahead of print]

PMID:
30885062
19.

Florid T follicular helper cell hyperplasia associated with extranodal marginal zone lymphoma: a diagnostic pitfall which may mimic T cell lymphoma.

Vroobel KM, O'Connor S, Cunningham D, Wren D, Sharma B, Wotherspoon A, Attygalle AD.

Histopathology. 2019 Mar 12. doi: 10.1111/his.13858. [Epub ahead of print] No abstract available.

PMID:
30860612
20.

Pseudoprogression on treatment with immune-checkpoint inhibitors in patients with gastrointestinal malignancies: Case series and short literature review.

Michalarea V, Fontana E, Garces AI, Williams A, Smyth EC, Picchia S, Rao S, Chau I, Cunningham D, Bali MA.

Curr Probl Cancer. 2019 Feb 21. pii: S0147-0272(18)30318-0. doi: 10.1016/j.currproblcancer.2019.01.008. [Epub ahead of print]

PMID:
30827742
21.

Response to Letter to the Editor on "When Should Complete Blood Count Tests Be Performed in Primary Total Hip Arthroplasty Patients?"

Kildow BJ, Howell EP, Karas V, Baumgartner WT, Cunningham DJ, Green CL, Bolognesi MP, Seyler TM.

J Arthroplasty. 2019 May;34(5):1040-1041. doi: 10.1016/j.arth.2019.01.045. Epub 2019 Feb 14. No abstract available.

PMID:
30827718
22.

The Effect of Patient Characteristics on 1 to 2-Year and Minimum 5-Year Outcomes After Total Ankle Arthroplasty.

Cunningham DJ, DeOrio JK, Nunley JA, Easley ME, Adams SB.

J Bone Joint Surg Am. 2019 Feb 6;101(3):199-208. doi: 10.2106/JBJS.18.00313.

PMID:
30730479
23.

One-year pilot study on the effects of nitisinone on melanin in patients with OCA-1B.

Adams DR, Menezes S, Jauregui R, Valivullah ZM, Power B, Abraham M, Jeffrey BG, Garced A, Alur RP, Cunningham D, Wiggs E, Merideth MA, Chiang PW, Bernstein S, Ito S, Wakamatsu K, Jack RM, Introne WJ, Gahl WA, Brooks BP.

JCI Insight. 2019 Jan 24;4(2). pii: 124387. doi: 10.1172/jci.insight.124387. [Epub ahead of print]

24.

Unifying Children's Surgery and Anesthesia Stakeholders Across Institutions and Clinical Disciplines: Challenges and Solutions from Uganda.

Kisa P, Grabski DF, Ozgediz D, Ajiko M, Aspide R, Baird R, Barker G, Birabwa-Male D, Blair G, Cameron B, Cheung M, Cigliano B, Cunningham D, D'Agostino S, Duffy D, Evans F, Fitzgerald TN, Galiwango G, Gerolmini D, Gerolmini M, Kakembo N, Kambugu JB, Lakhoo K, Langer M, Muhumuza MF, Muzira A, Nabukenya MT, Naik-Mathuria B, Nakku D, Nankunda J, Ogwang M, Okello I, Penny N, Reimer E, Sabatini C, Sekabira J, Situma M, Ssenyonga P, Tumukunde J, Villalona G.

World J Surg. 2019 Jun;43(6):1435-1449. doi: 10.1007/s00268-018-04905-9.

PMID:
30617561
25.

Genomic loss of heterozygosity and survival in the REAL3 trial.

Smyth EC, Cafferkey C, Loehr A, Waddell T, Begum R, Peckitt C, Harding TC, Nguyen M, Okines AF, Raponi M, Rao S, Watkins D, Starling N, Middleton GW, Wadsley J, Mansoor W, Crosby T, Wotherspoon A, Chau I, Cunningham D.

Oncotarget. 2018 Nov 30;9(94):36654-36665. doi: 10.18632/oncotarget.26336. eCollection 2018 Nov 30.

26.

Immunotherapy and pancreatic cancer: unique challenges and potential opportunities.

Young K, Hughes DJ, Cunningham D, Starling N.

Ther Adv Med Oncol. 2018 Dec 17;10:1758835918816281. doi: 10.1177/1758835918816281. eCollection 2018. Review.

27.

Exercise intensity affects acute neurotrophic and neurophysiological responses poststroke.

Boyne P, Meyrose C, Westover J, Whitesel D, Hatter K, Reisman DS, Cunningham D, Carl D, Jansen C, Khoury JC, Gerson M, Kissela B, Dunning K.

J Appl Physiol (1985). 2019 Feb 1;126(2):431-443. doi: 10.1152/japplphysiol.00594.2018. Epub 2018 Dec 20.

PMID:
30571289
28.

Patient-level costs in margin re-excision for breast-conserving surgery.

Grant Y, Al-Khudairi R, St John E, Barschkett M, Cunningham D, Al-Mufti R, Hogben K, Thiruchelvam P, Hadjiminas DJ, Darzi A, Carter AW, Leff DR.

Br J Surg. 2019 Mar;106(4):384-394. doi: 10.1002/bjs.11050. Epub 2018 Dec 19.

PMID:
30566233
29.

Genomic and transcriptomic comparisons of closely related malaria parasites differing in virulence and sequestration pattern.

Lin JW, Reid AJ, Cunningham D, Böhme U, Tumwine I, Keller-Mclaughlin S, Sanders M, Berriman M, Langhorne J.

Version 2. Wellcome Open Res. 2018 Dec 6 [revised 2018 Jan 1];3:142. doi: 10.12688/wellcomeopenres.14797.2. eCollection 2018.

30.

Polymicrobial Infections in Hip Arthroplasty: Lower Treatment Success Rate, Increased Surgery, and Longer Hospitalization.

Kavolus JJ, Cunningham DJ, Rao SR, Wellman SS, Seyler TM.

J Arthroplasty. 2019 Apr;34(4):710-716.e3. doi: 10.1016/j.arth.2018.09.090. Epub 2018 Oct 9.

PMID:
30527896
31.

A seven-Gene Signature assay improves prognostic risk stratification of perioperative chemotherapy treated gastroesophageal cancer patients from the MAGIC trial.

Smyth EC, Nyamundanda G, Cunningham D, Fontana E, Ragulan C, Tan IB, Lin SJ, Wotherspoon A, Nankivell M, Fassan M, Lampis A, Hahne JC, Davies AR, Lagergren J, Gossage JA, Maisey N, Green M, Zylstra JL, Allum WH, Langley RE, Tan P, Valeri N, Sadanandam A.

Ann Oncol. 2018 Dec 1;29(12):2356-2362. doi: 10.1093/annonc/mdy407.

32.

Comparing Standard Versus Extended Culture Duration in Acute Hip and Knee Periprosthetic Joint Infection.

Klement MR, Cunningham DJ, Wooster BM, Wellman SS, Bolognesi MP, Green CL, Garrigues GE.

J Am Acad Orthop Surg. 2019 May 1;27(9):e437-e443. doi: 10.5435/JAAOS-D-17-00674.

PMID:
30431505
33.

SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer.

Robles-Zurita J, Boyd KA, Briggs AH, Iveson T, Kerr RS, Saunders MP, Cassidy J, Hollander NH, Tabernero J, Segelov E, Glimelius B, Harkin A, Allan K, McQueen J, Pearson S, Waterston A, Medley L, Wilson C, Ellis R, Essapen S, Dhadda AS, Hughes R, Falk S, Raouf S, Rees C, Olesen RK, Propper D, Bridgewater J, Azzabi A, Farrugia D, Webb A, Cunningham D, Hickish T, Weaver A, Gollins S, Wasan HS, Paul J.

Br J Cancer. 2018 Nov;119(11):1332-1338. doi: 10.1038/s41416-018-0319-z. Epub 2018 Nov 13.

PMID:
30420616
34.

Survival with nal-IRI (liposomal irinotecan) plus 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in per-protocol and non-per-protocol populations of NAPOLI-1: Expanded analysis of a global phase 3 trial.

Chen LT, Siveke JT, Wang-Gillam A, Li CP, Bodoky G, Dean AP, Shan YS, Jameson GS, Macarulla T, Lee KH, Cunningham D, Blanc JF, Chiu CF, Schwartsmann G, Braiteh FS, Mamlouk K, Belanger B, de Jong FA, Hubner RA.

Eur J Cancer. 2018 Dec;105:71-78. doi: 10.1016/j.ejca.2018.09.010. Epub 2018 Nov 8.

35.

Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience.

Khan K, Rane JK, Cunningham D, Rao S, Watkins D, Starling N, Kalaitzaki E, Forster M, Braconi C, Valeri N, Gerlinger M, Chau I.

Clin Colorectal Cancer. 2019 Mar;18(1):64-71.e1. doi: 10.1016/j.clcc.2018.09.010. Epub 2018 Sep 29.

PMID:
30404764
36.

A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors.

Van Cutsem E, Karaszewska B, Kang YK, Chung HC, Shankaran V, Siena S, Go NF, Yang H, Schupp M, Cunningham D.

Clin Cancer Res. 2019 Apr 15;25(8):2414-2423. doi: 10.1158/1078-0432.CCR-18-1337. Epub 2018 Oct 26.

PMID:
30366938
37.

Suppression of interferon gene expression overcomes resistance to MEK inhibition in KRAS-mutant colorectal cancer.

Wagner S, Vlachogiannis G, De Haven Brandon A, Valenti M, Box G, Jenkins L, Mancusi C, Self A, Manodoro F, Assiotis I, Robinson P, Chauhan R, Rust AG, Matthews N, Eason K, Khan K, Starling N, Cunningham D, Sadanandam A, Isacke CM, Kirkin V, Valeri N, Whittaker SR.

Oncogene. 2019 Mar;38(10):1717-1733. doi: 10.1038/s41388-018-0554-z. Epub 2018 Oct 23. Erratum in: Oncogene. 2019 May 30;:.

PMID:
30353166
38.

Possible Implications for Bundled Payment Models of Comorbidities and Complications as Drivers of Cost in Total Ankle Arthroplasty.

Cunningham D, Karas V, DeOrio JK, Nunley JA, Easley ME, Adams SB.

Foot Ankle Int. 2019 Feb;40(2):210-217. doi: 10.1177/1071100718805746. Epub 2018 Oct 21.

PMID:
30345807
39.

Third line treatment of advanced oesophagogastric cancer: A critical review of current evidence and evolving trends.

Edwards P, Davidson M, Calamai V, Cunningham D, Starling N.

Cancer Treat Rev. 2018 Dec;71:32-38. doi: 10.1016/j.ctrv.2018.10.009. Epub 2018 Oct 17. Review.

PMID:
30343173
40.

Cisplatin Substitution with Carboplatin During Radical Chemoradiotherapy for Oesophagogastric Carcinoma: Outcomes from a Tertiary Centre.

Athauda A, Watkins D, Mohammed K, Chau I, Starling N, Rao S, Tait D, Aitken K, Cunningham D.

Anticancer Res. 2018 Oct;38(10):5943-5949. doi: 10.21873/anticanres.12940.

PMID:
30275223
41.

Adaptable ligand donor strength: tracking transannular bond interactions in tris(2-pyridylmethyl)-azaphosphatrane (TPAP).

Thammavongsy Z, Cunningham DW, Sutthirat N, Eisenhart RJ, Ziller JW, Yang JY.

Dalton Trans. 2018 Oct 9;47(39):14101-14110. doi: 10.1039/c8dt03180k.

PMID:
30252015
42.

Identifying the role of neutrophil-to-lymphocyte ratio and platelets-to-lymphocyte ratio as prognostic markers in patients undergoing resection of pancreatic ductal adenocarcinoma.

Giakoustidis A, Neofytou K, Costa Neves M, Giakoustidis D, Louri E, Cunningham D, Mudan S.

Ann Hepatobiliary Pancreat Surg. 2018 Aug;22(3):197-207. doi: 10.14701/ahbps.2018.22.3.197. Epub 2018 Aug 31.

43.

NHS Scotland's community GP fellowship - a qualitative study of the first year.

Cunningham DE, Kane L, Denney M.

Educ Prim Care. 2018 Nov;29(6):336-342. doi: 10.1080/14739879.2018.1516518. Epub 2018 Sep 13.

PMID:
30208762
44.

Relationships between physical qualities and key performance indicators during match-play in senior international rugby union players.

Cunningham DJ, Shearer DA, Drawer S, Pollard B, Cook CJ, Bennett M, Russell M, Kilduff LP.

PLoS One. 2018 Sep 12;13(9):e0202811. doi: 10.1371/journal.pone.0202811. eCollection 2018.

45.

Neoadjuvant rectal score: run with the hare and hunt with the hounds.

Sclafani F, Kalaitzaki E, Cunningham D, Tait D, Brown G, Chau I.

Ann Oncol. 2018 Nov 1;29(11):2261-2262. doi: 10.1093/annonc/mdy403. No abstract available.

PMID:
30204839
46.

Fast molecular outflow from a dusty star-forming galaxy in the early Universe.

Spilker JS, Aravena M, Béthermin M, Chapman SC, Chen CC, Cunningham DJM, De Breuck C, Dong C, Gonzalez AH, Hayward CC, Hezaveh YD, Litke KC, Ma J, Malkan M, Marrone DP, Miller TB, Morningstar WR, Narayanan D, Phadke KA, Sreevani J, Stark AA, Vieira JD, Weiß A.

Science. 2018 Sep 7;361(6406):1016-1019. doi: 10.1126/science.aap8900.

PMID:
30190403
47.

Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

Khan KH, Cunningham D, Werner B, Vlachogiannis G, Spiteri I, Heide T, Mateos JF, Vatsiou A, Lampis A, Damavandi MD, Lote H, Huntingford IS, Hedayat S, Chau I, Tunariu N, Mentrasti G, Trevisani F, Rao S, Anandappa G, Watkins D, Starling N, Thomas J, Peckitt C, Khan N, Rugge M, Begum R, Hezelova B, Bryant A, Jones T, Proszek P, Fassan M, Hahne JC, Hubank M, Braconi C, Sottoriva A, Valeri N.

Cancer Discov. 2018 Oct;8(10):1270-1285. doi: 10.1158/2159-8290.CD-17-0891. Epub 2018 Aug 30.

48.

Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.

Mansukhani S, Barber LJ, Kleftogiannis D, Moorcraft SY, Davidson M, Woolston A, Proszek PZ, Griffiths B, Fenwick K, Herman B, Matthews N, O'Leary B, Hulkki S, Gonzalez De Castro D, Patel A, Wotherspoon A, Okachi A, Rana I, Begum R, Davies MN, Powles T, von Loga K, Hubank M, Turner N, Watkins D, Chau I, Cunningham D, Lise S, Starling N, Gerlinger M.

Clin Chem. 2018 Nov;64(11):1626-1635. doi: 10.1373/clinchem.2018.289629. Epub 2018 Aug 27.

49.

Rapid access clinic for unexplained lymphadenopathy and suspected malignancy: prospective analysis of 1000 patients.

Kühnl A, Cunningham D, Hutka M, Peckitt C, Rozati H, Morano F, Chong I, Gillbanks A, Wotherspoon A, Harris M, Murray T, Chau I.

BMC Hematol. 2018 Aug 14;18:19. doi: 10.1186/s12878-018-0109-0. eCollection 2018.

50.

Patient Risk Factors Do Not Impact 90-Day Readmission and Emergency Department Visitation After Total Ankle Arthroplasty: Implications for the Comprehensive Care for Joint Replacement (CJR) Bundled Payment Plan.

Cunningham D, Karas V, DeOrio J, Nunley J, Easley M, Adams S.

J Bone Joint Surg Am. 2018 Aug 1;100(15):1289-1297. doi: 10.2106/JBJS.17.01149.

PMID:
30063591

Supplemental Content

Loading ...
Support Center